Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Arch Soc Esp Oftalmol (Engl Ed) ; 95(9): 463-466, 2020 Sep.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32336548

RESUMO

Differential diagnosis between a melanoma and a pseudomelanoma requires many years of experience and ocular studies, and requires paying attention to the smallest details. The case is presented of a 57 year-old male with an adenoma of the ciliary body pigment epithelium that was treated with an enucleation of the eye due to a suspicion of a choroidal melanoma.

2.
Arch Soc Esp Oftalmol (Engl Ed) ; 94(9): 436-440, 2019 Sep.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-31272707

RESUMO

OBJECTIVE: To propose guidelines for the diagnosis and treatment of facial dystonia prepared by a group of experts in orbit and oculoplastics from the Iberoamerican Oculoplastic Society. MATERIAL AND METHODS: An interactive discussion between the expert panel and those attending the 6th Iberoamerican Society of Oculoplastics Congress, which took place at the Hospital Nuestra Señora de la Luz in Mexico City on 22 October 2018, providing their personal experience based on evidence for diagnosis and treatment of facial dystonia. Around 200 ophthalmologists specialised in oculoplastics from North, Central and South America, Spain, and Portugal were involved. Discussion was focused on the following themes: pathophysiology, diagnosis, medical management, and surgical management. CONCLUSIONS: Facial dystonia diagnosis is clinical; therefore, image studies are rarely needed. The ophthalmologist is generally the first physician to be consulted, and is able to be the treating physician, with the exception of specific cases of hemifacial spasm where management with neurosurgery may be beneficial. Botulinum toxin is the treatment of choice. Treatment with oral neuroleptics and myectomy of the orbicularis oculi muscle are reserved for refractory cases, since these do not have an adequate clinical response as first choice treatments. Persistent use of botulinum toxin does not modify the natural course of the disease.


Assuntos
Distúrbios Distônicos/diagnóstico , Distúrbios Distônicos/tratamento farmacológico , Face , Antipsicóticos/uso terapêutico , Blefarospasmo/diagnóstico , Blefarospasmo/tratamento farmacológico , Toxinas Botulínicas/uso terapêutico , Técnicas de Diagnóstico Oftalmológico , Gerenciamento Clínico , Distúrbios Distônicos/fisiopatologia , Distúrbios Distônicos/cirurgia , Espasmo Hemifacial/diagnóstico , Espasmo Hemifacial/tratamento farmacológico , Espasmo Hemifacial/cirurgia , Humanos , Cirurgia de Descompressão Microvascular , Músculo Esquelético/cirurgia , Prognóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA